A Phase 2 Randomised Clinical Trial Assessing the Tolerability of Two Different Ratios of Medicinal Cannabis in Patients With High Grade Gliomas

Overview of attention for article published in Frontiers in oncology, May 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 206 X posts from 162 X users, with an upper bound of 681,119 followers.

RT @ProudyMan1: @popatlab @BioactiveMat @Ravi_raj_singh1 @UQPharmacy @iitdelhi Fantastic work! Love to see some ncRNAs research on the endo…

@popatlab @BioactiveMat @Ravi_raj_singh1 @UQPharmacy @iitdelhi Fantastic work! Love to see some ncRNAs research on the endocannabinoid system & GBM . See generally: https://t.co/lb3xOprq3f https://t.co/C3qAPFatvy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 202 additional X posts.